Cargando…
COVID-19 vaccination: Prioritization of at risk groups
Autores principales: | Lundon, Dara J., Khusid, Johnathan A., Tsao, Che-kai, Patel, Vaibhav, Kyprianou, Natasha, Tewari, Ashutosh, Wiklund, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029295/ https://www.ncbi.nlm.nih.gov/pubmed/36861731 http://dx.doi.org/10.1016/j.urolonc.2021.03.021 |
Ejemplares similares
-
The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic
por: Izadmehr, Sudeh, et al.
Publicado: (2021) -
Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer
por: Gaglani, Simita, et al.
Publicado: (2021) -
Increased Hospitalization and Mortality from COVID-19 in Prostate Cancer Patients
por: Chakravarty, Dimple, et al.
Publicado: (2021) -
What Stone-formers Should Know About Vitamin C and D Supplementation in the COVID-19 Era
por: Khusid, Johnathan A., et al.
Publicado: (2020) -
A Decision Aide for the Risk Stratification of GU Cancer Patients at Risk of SARS-CoV-2 Infection, COVID-19 Related Hospitalization, Intubation, and Mortality
por: Lundon, Dara J., et al.
Publicado: (2020)